Getz Vilde, Munkhaugen John, Lie Hanne C, Dammen Toril
Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Behavioural Medicine, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Front Psychol. 2023 Mar 22;14:1060701. doi: 10.3389/fpsyg.2023.1060701. eCollection 2023.
Smoking is common in patients with cardiovascular disease. Despite strong recommendations for cessation and the existence of efficacious pharmacological and behavioral interventions, cessation rates remain low. Therefore, in this study, we explore perceived facilitators and barriers to smoking cessation in patients with atherosclerotic cardiovascular disease who have participated in a cessation intervention study.
Participants ( = 10) from the intervention arm of a randomized controlled study with access to free cessation support and pharmacological aids completed a semi-structured, in-depth telephone interview after a 6-monthfollow-up between October 2021 and July 2022. The interviews were audio recorded, transcribed, and analyzed according to principles of thematic analysis.
The mean age was 65.7 (range: 55-79) years, and three of the 10 participants were women. Among the participants, five had quit smoking, three had relapsed, and two were persistent smokers. The themes identified encompassed barriers and facilitators to cessation, both including individual and contextual factors. Barriers included the upsides of smoking, difficult life situations, addiction to smoking, smoking in social circles, perceived lack of support and understanding from health professionals. Facilitators included intrinsic motivation, concerns about the health condition, financial implications, specific behavioral strategies, positive influence from the social environment, and helpful components of the cessation intervention.
Smokers with cardiovascular disease who have attended a cessation intervention study report several facilitators weighted against barriers, interacting with the intention to cease smoking. The most important potentially modifiable factors of significance for cessation identified may be addressed through motivational interviews and focus groups with other smokers.
吸烟在心血管疾病患者中很常见。尽管强烈建议戒烟,且存在有效的药物和行为干预措施,但戒烟率仍然很低。因此,在本研究中,我们探讨了参与戒烟干预研究的动脉粥样硬化性心血管疾病患者对戒烟的感知促进因素和障碍。
来自一项随机对照研究干预组的参与者(n = 10),可获得免费的戒烟支持和药物辅助,在2021年10月至2022年7月的6个月随访后,完成了一次半结构化的深入电话访谈。访谈进行了录音、转录,并根据主题分析原则进行分析。
平均年龄为65.7岁(范围:55 - 79岁),10名参与者中有3名女性。参与者中,5人已戒烟,3人复吸,2人仍为持续吸烟者。确定的主题包括戒烟的障碍和促进因素,两者都包括个人和背景因素。障碍包括吸烟的好处、艰难的生活状况、对吸烟的成瘾、社交圈子中的吸烟行为、认为缺乏来自医护人员的支持和理解。促进因素包括内在动力、对健康状况的担忧、经济影响、特定的行为策略、社会环境的积极影响以及戒烟干预的有益组成部分。
参加戒烟干预研究的心血管疾病吸烟者报告了几个促进因素与障碍相权衡的情况,这些与戒烟意愿相互作用。确定的对戒烟具有重要意义的最重要的潜在可改变因素,可通过与其他吸烟者进行动机访谈和焦点小组讨论来解决。